Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine + dexmedetomidine vs propofol + midazolam for DISE in OSAS
ChiCTR2500102931Phase 4Not yet recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine and dexmedetomidine in obstructive sleep apnea hypopnea syndrome (OSAHS) (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoint: EEG Bispectral Index (BIS). Planned start May 2025; status: not yet recruiting.
02
Drugs
esketaminedexmedetomidine
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ChiCTR2500102931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102931.